Ironwood: Medicare Pricing Shift Is A Tailwind, Not a Worry - Tactical Long
Ironwood's January 2026 guidance shows LINZESS U.S. net sales of $1.125-1.175B and total revenue of $450-475M after a list price reduction that improved net pricing. The market overreacted to Medicare pricing noise earlier; fundamentals and cash flow now support a tactical long. Trade plan: enter $3.99, stop $3.20, target $6.00 over a mid-term 45 t…